0000921895-19-003059.txt : 20191223 0000921895-19-003059.hdr.sgml : 20191223 20191223155302 ACCESSION NUMBER: 0000921895-19-003059 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Health Insurance Innovations, Inc. CENTRAL INDEX KEY: 0001561387 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 461282634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-87331 FILM NUMBER: 191305820 BUSINESS ADDRESS: STREET 1: 15438 N. FLORIDA AVENUE STREET 2: SUITE 201 CITY: TAMPA STATE: FL ZIP: 33613 BUSINESS PHONE: 813-397-1187 MAIL ADDRESS: STREET 1: 15438 N. FLORIDA AVENUE STREET 2: SUITE 201 CITY: TAMPA STATE: FL ZIP: 33613 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Voss Capital LLC CENTRAL INDEX KEY: 0001730145 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 2365 RICE BLVD. STREET 2: SUITE 217 CITY: HOUSTON STATE: TX ZIP: 77055 BUSINESS PHONE: (713) 328-1126 MAIL ADDRESS: STREET 1: 2365 RICE BLVD. STREET 2: SUITE 217 CITY: HOUSTON STATE: TX ZIP: 77055 SC 13D 1 sc13d10925hea_12232019.htm THE SCHEDULE 13D

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No.  )1

Health Insurance Innovations, Inc.

(Name of Issuer)

Class A Common Stock, $0.001 par value

(Title of Class of Securities)

42225K106

(CUSIP Number)

Voss Capital, LLC

3773 Richmond, Suite 500

Houston, Texas 77046

(212) 721-0494

 

ANDREW FREEDMAN, ESQ.

OLSHAN FROME WOLOSKY LLP

1325 Avenue of the Americas

New York, New York 10019

(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

December 23, 2019

(Date of Event Which Requires Filing of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☒.

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

 

 

 

1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No. 42225K106

  1   NAME OF REPORTING PERSON  
         
        VOSS VALUE FUND, L.P.  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        WC  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        TEXAS  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         808,541*  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         - 0 -  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          808,541*  
    10   SHARED DISPOSITIVE POWER  
           
          - 0 -  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        808,541*  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        6.6%*  
  14   TYPE OF REPORTING PERSON  
         
        PN  

 

 

* Includes 46,400 Shares underlying certain call options exercisable within sixty days hereof.

2

CUSIP No. 42225K106

  1   NAME OF REPORTING PERSON  
         
        VOSS ADVISORS, LP  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        OO  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        TEXAS  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         808,541*  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         - 0 -  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          808,541*  
    10   SHARED DISPOSITIVE POWER  
           
          - 0 -  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        808,541*  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        6.6%*  
  14   TYPE OF REPORTING PERSON  
         
        PN  

 

* Includes 46,400 Shares underlying certain call options exercisable within sixty days hereof.

3

CUSIP No. 42225K106

 

  1   NAME OF REPORTING PERSON  
         
        VOSS ADVISORS GP, LLC  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        OO  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        TEXAS  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         808,541*  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         - 0 -  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          808,541*  
    10   SHARED DISPOSITIVE POWER  
           
          - 0 -  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        808,541*  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        6.6%*  
  14   TYPE OF REPORTING PERSON  
         
        OO  

  

 

* Includes 46,400 Shares underlying certain call options exercisable within sixty days hereof.

4

CUSIP No. 42225K106

 

  1   NAME OF REPORTING PERSON  
         
        VOSS CAPITAL, LLC  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        OO  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        TEXAS  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         1,283,109*  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         - 0 -  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          1,283,109*  
    10   SHARED DISPOSITIVE POWER  
           
          - 0 -  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        1,283,109*  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        10.4%*  
  14   TYPE OF REPORTING PERSON  
         
        OO  

 

* Includes 46,400 Shares underlying certain call options exercisable within sixty days hereof.

5

CUSIP No. 42225K106

 

  1   NAME OF REPORTING PERSON  
         
        TRAVIS W. COCKE  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        OO  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        USA  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         1,283,109*  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         - 0 -  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          1,283,109*  
    10   SHARED DISPOSITIVE POWER  
           
          - 0 -  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        1,283,109*  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        10.4%*  
  14   TYPE OF REPORTING PERSON  
         
        IN  

 

 

* Includes 46,400 Shares underlying certain call options exercisable within sixty days hereof.

 

6

CUSIP No. 42225K106

The following constitutes the Schedule 13D filed by the undersigned (the “Schedule 13D”). Prior to filing the Schedule 13D, the Reporting Persons (defined below) had relied on Rule 13d-1(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which provides that a Schedule 13G shall be filed within 45 days after the end of the calendar year in which the person became obligated under Rule 13d-1(b).

 

Item 1.Security and Issuer.

This statement relates to the Class A Common Stock, $0.001 par value per share (the “Shares”), of Health Insurance Innovations, Inc., a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 15438 North Florida Avenue, Suite 201, Tampa, Florida 33613.

Item 2.Identity and Background.
(a)This statement is filed by:
(i)Voss Value Fund, L.P., a Texas limited partnership (“Voss Value Fund”), with respect to the Shares directly and beneficially owned by it;

 

(ii)Voss Advisors, LP, a Texas limited partnership (“Voss Advisors”), as the general partner of Voss Value Fund;

 

(iii)Voss Advisors GP, LLC, a Texas limited liability company (“Voss GP”), as the general partner of Voss Advisors;

 

(iv)Voss Capital, LLC, a Texas limited liability company (“Voss Capital”), as the investment manager of Voss Value Fund and a certain managed account (the “Voss Managed Account”); and

 

(v)Travis W. Cocke, as the managing member of Voss Capital and Voss GP.

 

Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Each of the Reporting Persons is party to that certain Joint Filing Agreement, as further described in Item 6. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.

(b)       The address of the principal office of each of the Reporting Persons is 3773 Richmond, Suite 500, Houston, Texas 77046.

(c)       The principal business of Voss Value Fund is investing in securities. The principal business of Voss Advisors is serving as the general partner of Voss Value Fund. The principal business of Voss GP is serving as the general partner of Voss Advisors. The principal business of Voss Capital is serving as the investment manager of each of Voss Value Fund and the Voss Managed Account. Mr. Cocke serves as the managing member of each of Voss Capital and Voss GP.

(d)       No Reporting Person has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e)       No Reporting Person has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

7

CUSIP No. 42225K106

(f)       Voss Value Fund, Voss Advisors, Voss GP and Voss Capital are organized under the laws of the State of Texas. Mr. Cocke is a citizen of the United States of America.

Item 3.Source and Amount of Funds or Other Consideration.

The Shares purchased by Voss Value Fund and held in the Voss Managed Account were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market transactions. The aggregate purchase price of the 762,141 Shares beneficially owned by Voss Value Fund is approximately $16,664,950, including brokerage commissions. The aggregate purchase price of certain call options exercisable into 46,400 Shares that may be deemed to be beneficially owned by Voss Value Fund, as further described in Item 6 below, is approximately $83,102, including brokerage commissions. The aggregate purchase price of the 474,568 Shares held in the Voss Managed Account is approximately $10,220,477, including brokerage commissions.

Item 4.Purpose of Transaction.

The Reporting Persons purchased the Shares based on the Reporting Persons’ belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.

 

The Reporting Persons believe that the Issuer is one of the most misunderstood companies in the public markets. The Reporting Persons believe that the Issuer’s Shares are deeply undervalued and do not reflect the high quality of its business, its leading position in the industry, and the Issuer’s potential for long-term revenue, earnings and cash flow growth.

 

As the Issuer’s individual and family plan (“IFP”) business goes into partial run-off, throwing off prodigious free cash flow in 2020 and beyond, the Reporting Persons believe that the IFP business alone is worth at least $250 million due to the conservatively marked contract assets on the balance sheet. The Reporting Persons are encouraged to hear the Issuer reiterate its commitment to investing in and growing its promising Medicare business. The Issuer’s most direct trading comparable, eHealth Inc. (“EHTH”) (NASDAQ: EHTH), is valued 4.5x 2020 revenue estimates. If the Issuer were to generate close to $150 - $200 million of Medicare related revenue in 2020 and were ascribed EHTH’s 4.5x forward revenue multiple (despite growing even faster than EHTH and being more profitable), that segment alone would be worth multiples of the current Share price.

 

The M&A environment in the insurance technology and brokerage space has rarely been more active than it is today with numerous well capitalized private equity firms and strategic acquirers buying similar businesses at valuation multiples above 4.0x EV/Sales. The table below shows precedent transactions that have occurred just within the last eight months.

8

CUSIP No. 42225K106

 

The Reporting Persons understand the Board of Directors’ (the “Board”) desire to take advantage of this environment of active M&A and the Reporting Persons intend to help management unlock the substantial embedded value for all stockholders.

 

No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in communications with management and the Board to discuss their views, including the composition of the Board and corporate governance practices, engaging in discussions with stockholders of the Issuer or other third parties about the Issuer and the Reporting Persons’ investment, including potential business combinations or dispositions involving the Issuer or certain of its businesses, making recommendations or proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition), potential business combinations or dispositions involving the Issuer or certain of its businesses, or suggestions for improving the Issuer’s financial and/or operational performance, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, including swaps and other derivative instruments, or changing their intention with respect to any and all matters referred to in Item 4.

 

Item 5.Interest in Securities of the Issuer.

The aggregate percentage of Shares reported owned by each person named herein is based upon 12,296,567 Shares outstanding, as of November 8, 2019, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2019.

A.Voss Value Fund
(a)As of the close of business on December 20, 2019, the Voss Value Fund beneficially owned 808,541 Shares, including 46,400 Shares underlying certain call options.

Percentage: Approximately 6.6%

9

CUSIP No. 42225K106

(b)1. Sole power to vote or direct vote: 808,541
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 808,541
4. Shared power to dispose or direct the disposition: 0

 

(c)The transactions in the Shares by Voss Value Fund during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
B.Voss Advisors
(a)Voss Advisors, as the general partner of Voss Value Fund, may be deemed the beneficial owner of the 808,541 Shares owned by Voss Value Fund.

Percentage: Approximately 6.6%

(b)1. Sole power to vote or direct vote: 808,541
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 808,541
4. Shared power to dispose or direct the disposition: 0

 

(c)Voss Advisors has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of Voss Value Fund during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
C.Voss GP
(a)Voss GP, as the general partner of Voss Advisors, may be deemed the beneficial owner of the 808,541 Shares owned by Voss Value Fund.

Percentage: Approximately 6.6%

(b)1. Sole power to vote or direct vote: 808,541
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 808,541
4. Shared power to dispose or direct the disposition: 0

 

(c)Voss GP has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of Voss Value Fund during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
D.Voss Capital
(a)As of the close of business on December 20, 2019, 474,568 Shares were held in the Voss Managed Account. Voss Capital, as the investment manager of Voss Value Fund, may be deemed to beneficially own the 808,541 Shares owned by Voss Value Fund.

Percentage: Approximately 10.4%

(b)1. Sole power to vote or direct vote: 1,283,109
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 1,283,109
4. Shared power to dispose or direct the disposition: 0

 

10

CUSIP No. 42225K106

(c)The transactions in the Shares by Voss Capital through the Voss Managed Account and on behalf of Voss Value Fund during the past sixty days are set forth in Schedule A and are incorporated herein by reference.
E.Mr. Cocke
(a)Mr. Cocke, as the managing member of each of Voss GP and Voss Capital, may be deemed the beneficial owner of the (i) 808,541 Shares owned by Voss Value Fund and (ii) 474,568 Shares held in the Voss Managed Account.

Percentage: Approximately 10.4%

(b)1. Sole power to vote or direct vote: 1,283,109
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 1,283,109
4. Shared power to dispose or direct the disposition: 0

 

(c)Mr. Cocke has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of Voss Value Fund and through the Voss Managed Account during the past sixty days are set forth in Schedule A and are incorporated herein by reference.

The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Exchange Act, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

(d)No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
(e)Not applicable.
Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

Voss Value Fund sold exchange-listed American-style call options referencing 4,800 Shares, which have an exercise price of $19 and expire on January 17, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund purchased exchange-listed American-style call options referencing 35,000 Shares, which have an exercise price of $25 and expire on January 17, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund sold exchange-listed American-style put options referencing an aggregate of 15,000 Shares and 10,000 Shares, which have an exercise price of $20 and $26, respectively, and expire on January 17, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

11

CUSIP No. 42225K106

Voss Value Fund sold exchange-listed American-style call options referencing an aggregate of 10,000, 21,700 Shares and 5,000 Shares, which have an exercise price of $16, $18 and $21, respectively, and expire on February 21, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund purchased exchange-listed American-style call options referencing 1,400 Shares, which have an exercise price of $34 and expire on February 21, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund sold exchange-listed American-style put options referencing an aggregate of 2,400 Shares, 15,000 Shares, 20,000 Shares, 10,000 Shares and 10,000 Shares, which have an exercise price of $13, $15, $18, $20 and $22, respectively, and expire on February 21, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Capital through the Voss Managed Account sold exchange-listed American-style put options referencing an aggregate of 4,000 Shares, which have an exercise price of $23, and expire on February 21, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund purchased exchange-listed American-style call options referencing 10,000 Shares, which have an exercise price of $10 and expire on May 15, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund sold exchange-listed American-style call options referencing an aggregate of 10,000 Shares, 20,000 Shares and 10,000 Shares, which have an exercise price of $17, $19, and $21, respectively, and expire on May 15, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund sold exchange-listed American-style put options referencing an aggregate of 10,000 Shares, 10,000 Shares and 10,00 Shares, which have an exercise price of $14, $19 and $23, respectively, and expire on May 15, 2020, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund sold exchange-listed American-style call options referencing an aggregate of 20,000 Shares, 15,000 Shares and 2,400 Shares, which have an exercise price of $18, $22 and $30, respectively, and expire on January 15, 2021, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund sold exchange-listed American-style put options referencing an aggregate of 10,000 Shares, 10,000 Shares and 10,000 Shares, which have an exercise price of $10, $15 and $22, respectively, and expire on January 15, 2021, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Capital through the Voss Managed Account sold exchange-listed American-style put options referencing an aggregate of 3,900 Shares, which have an exercise price of $25, and expire on January 21, 2022, as further detailed in Schedule A, which is incorporated herein by reference.

Voss Value Fund sold exchange-listed American-style call options referencing an aggregate of 10,000 Shares, which have an exercise price of $25, and expire on January 21, 2022, as further detailed in Schedule A, which is incorporated herein by reference.

12

CUSIP No. 42225K106

On December 23, 2019, the Reporting Persons entered into a Joint Filing Agreement. The Joint Filing Agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

Item 7.Material to be Filed as Exhibits.
99.1Joint Filing Agreement by and among Voss Value Fund, L.P., Voss Advisors, LP, Voss Advisors GP, LLC, Voss Capital, LLC and Travis W. Cocke, dated December 23, 2019.

13

CUSIP No. 42225K106

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: December 23, 2019

  Voss Value Fund, L.P.
   
  By:

Voss Capital, LLC

Investment Manager

     
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

  Voss Advisors, LP  
   
  By:

Voss Advisors GP, LLC

General Partner

     
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

  Voss Advisors GP, LLC
   
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

  Voss Capital LLC
   
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

 

/s/ Travis W. Cocke

  Travis W. Cocke

 

14

CUSIP No. 42225K106

 

Schedule A

Transactions in the Shares During the Past Sixty Days

Nature of the Transaction

Securities

Purchased/(Sold)

Price Per

Share($)

Date of

Purchase / Sale

 

Voss Value Fund, L.P.

 

Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($18 Strike Price) (2,500) 18.0000 10/24/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($16 Strike Price) (600) 16.0000 10/24/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($15 Strike Price) (2,500) 15.0000 10/24/2019
Sale of Class A Common Stock Upon Assignment December 2019 Call Options ($15 Strike Price) (5,800) 15.0000 10/24/2019
Purchase of Class A Common Stock 5,000 26.9364 10/25/2019
Purchase of Class A Common Stock 6,076 27.0964 10/25/2019
Sale of February 2020 Call Option ($27 Strike Price)1 (3,000) 3.9000 10/25/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($17 Strike Price) (600) 17.0000 10/28/2019
Sale of January 2020 Call Option ($26 Strike Price)2 (6,100) 3.5000 10/28/2019
Purchase of December 2019 Put Option ($13 Strike Price)3 2,400 0.2000 10/29/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($18 Strike Price) (300) 18.0000 10/31/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($14 Strike Price) (1,400) 14.0000 10/31/2019
Purchase of November 2019 Put Option ($20 Strike Price)4 4,900 0.4000 10/31/2019
Purchase of December 2019 Put Option ($15 Strike Price)3 4,700 0.3500 10/31/2019

 

 

CUSIP No. 42225K106

 

Purchase of Class A Common Stock 608 25.3810 11/01/2019
Purchase of December 2019 Put Option ($20 Strike Price)3 4,200 1.3500 11/04/2019
Sale of February 2020 Call Option ($28 Strike Price)1 (10,000) 2.6000 11/04/2019
Purchase of November 2019 Put Option ($18 Strike Price)4 9,600 0.2500 11/05/2019
Purchase of November 2019 Put Option ($22 Strike Price)4 300 0.9500 11/05/2019
Purchase of November 2019 Put Option ($24 Strike Price)4 1,000 1.7000 11/05/2019
Purchase of November 2019 Put Option ($25 Strike Price)4 2,500 2.3000 11/05/2019
Purchase of December 2019 Put Option ($13 Strike Price)3 7,600 0.2500 11/05/2019
Purchase of December 2019 Put Option ($20 Strike Price)3 5,800 1.4500 11/05/2019
Purchase of November 2019 Call Option ($28 Strike Price)5 6,100 0.6000 11/06/2019
Purchase of January 2020 Call Option ($35 Strike Price)2 10,000 0.6500 11/06/2019
Purchase of November 2019 Put Option ($22 Strike Price)4 7,600 1.1000 11/06/2019
Purchase of November 2019 Put Option ($25 Strike Price)4 1,300 2.5000 11/06/2019
Purchase of February 2020 Call Option ($35 Strike Price)1 6,100 1.1000 11/08/2019
Purchase of December 2019 Call Option ($34 Strike Price)6 5,000 0.5000 11/08/2019
Purchase of December 2019 Put Option ($13 Strike Price)3 300 4.7000 11/08/2019
Purchase of November 2019 Put Option ($20 Strike Price)4 10,000 0.5000 11/12/2019
Purchase of January 2020 Call Option ($20 Strike Price)2 3,600 5.3000 11/12/2019
Purchase of January 2020 Call Option ($23 Strike Price)2 10,000 3.3000 11/12/2019
Purchase of January 2020 Put Option ($16 Strike Price)7 10,000 0.6000 11/12/2019
Purchase of January 2020 Put Option ($19 Strike Price)7 10,000 1.3000 11/12/2019
Purchase of January 2020 Put Option ($20 Strike Price)7 10,000 1.7500 11/12/2019
Purchase of January 2020 Put Option ($25 Strike Price)7 10,000 4.0000 11/12/2019
Purchase of February 2020 Put Option ($25 Strike Price)8 10,000 0.3000 11/12/2019
Purchase of November 2019 Call Option ($21 Strike Price)5 10,000 3.9000 11/12/2019

 

 

CUSIP No. 42225K106

 

Purchase of November 2019 Call Option ($23 Strike Price)5 10,000 2.3000 11/12/2019
Purchase of November 2019 Put Option ($25 Strike Price)4 1,800 1.5500 11/12/2019
Purchase of December 2019 Call Option ($25 Strike Price)6 5,000 2.2500 11/12/2019
Purchase of December 2019 Put Option ($14 Strike Price)3 10,000 0.2500 11/12/2019
Purchase of December 2019 Put Option ($27 Strike Price)3 2,200 4.5000 11/12/2019
Purchase of Class A Common Stock 10,000 23.9650 11/13/2019
Sale of January 2021 Put Option ($22 Strike Price)9 (10,000) 7.7000 11/13/2019
Sale of January 2020 Put Option ($23 Strike Price)7 (10,000) 3.0000 11/13/2019
Sale of December 2019 Put Option ($23 Strike Price)3 (25,000) 2.2500 11/13/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($14 Strike Price) (3,600) 14.0000 11/14/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($19 Strike Price) (10,600) 19.0000 11/14/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($20 Strike Price) (5,000) 20.0000 11/14/2019
Purchase of Class A Common Stock 6,005 23.5843 11/14/2019
Purchase of January 2021 Call Option ($30 Strike Price)10 3,700 4.2000 11/14/2019
Purchase of January 2020 Call Option ($21 Strike Price)2 5,000 4.0000 11/14/2019
Purchase of January 2020 Call Option ($23 Strike Price)2 5,000 2.9000 11/14/2019
Purchase of January 2020 Call Option ($26 Strike Price)2 11,100 1.9000 11/14/2019
Purchase of February 2020 Call Option ($27 Strike Price)1 1,800 2.0000 11/14/2019
Purchase of November 2019 Call Option ($20 Strike Price)5 10,000 3.4000 11/14/2019
Purchase of November 2019 Call Option ($23 Strike Price)5 10,000 0.7000 11/14/2019
Purchase of November 2019 Put Option ($25 Strike Price)4 7,400 1.5000 11/14/2019
Sale of February 2020 Put Option ($23 Strike Price)8 (6,000) 4.0000 11/14/2019

 

 

CUSIP No. 42225K106

 

Sale of November 2019 Call Option ($20 Strike Price)5 (5,000) 3.3500 11/14/2019
Sale of December 2019 Put Option ($23 Strike Price)3 (10,000) 2.1000 11/14/2019
Purchase of Class A Common Stock Upon Assignment of November 2019 Put Options ($32 Strike Price) 10,000 32.0000 11/15/2019
Purchase of Class A Common Stock Upon Assignment of November 2019 Put Options ($30 Strike Price) 5,000 30.0000 11/15/2019
Purchase of Class A Common Stock Upon Assignment of November 2019 Put Options ($29 Strike Price) 5,000 29.0000 11/15/2019
Purchase of Class A Common Stock Upon Assignment of November 2019 Put Options ($27 Strike Price) 100 27.0000 11/15/2019
Sale of Class A Common Stock Upon Assignment of November 2019 Call Options ($21 Strike Price) (2,500) 21.0000 11/15/2019
Sale of Class A Common Stock Upon Assignment of November 2019 Call Options ($19 Strike Price) (9,400) 19.0000 11/15/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($18 Strike Price) (7,200) 18.0000 11/15/2019
Sale of Class A Common Stock Upon Assignment of November  2019 Call Options ($17 Strike Price) (8,600) 17.0000 11/15/2019
Sale of Class A Common Stock Upon Assignment of November 2019 Call Options ($15 Strike Price) (3,100) 15.0000 11/15/2019
Sale of Class A Common Stock Upon Assignment of November 2019 Call Options ($16 Strike Price) (1,400) 16.0000 11/15/2019
Purchase of Class A Common Stock 6,376 22.7420 11/15/2019
Purchase of Class A Common Stock 10,000 23.3869 11/15/2019
Purchase of Class A Common Stock 8,759 22.9739 11/15/2019

 

 

CUSIP No. 42225K106

 

Purchase of February 2020 Call Option ($27 Strike Price)1 1,200 1.8700 11/15/2019
Purchase of November 2019 Call Option ($21 Strike Price)5 10,000 2.3500 11/15/2019
Purchase of Class A Common Stock 20,000 21.0168 11/18/2019
Purchase of Class A Common Stock 10,000 21.1971 11/18/2019
Purchase of February 2020 Call Option ($21 Strike Price)1 10,000 2.7300 11/18/2019
Purchase of February 2020 Call Option ($23 Strike Price)1 10,000 2.0500 11/18/2019
Purchase of February 2020 Call Option ($24 Strike Price)1 10,000 1.7500 11/18/2019
Purchase of Class A Common Stock 10,000 19.5944 11/19/2019
Purchase of Class A Common Stock 20,000 19.6033 11/19/2019
Purchase of January 2020 Call Option ($18 Strike Price)2 5,000 2.9000 11/19/2019
Purchase of January 2020 Call Option ($22 Strike Price)2 10,000 1.9000 11/19/2019
Purchase of January 2020 Call Option ($24 Strike Price)2 5,000 0.9280 11/19/2019
Purchase of February 2020 Call Option ($20 Strike Price)1 10,000 2.6000 11/19/2019
Purchase of February 2020 Call Option ($28 Strike Price)1 10,000 0.8200 11/19/2019
Purchase of December 2019 Call Option ($19 Strike Price)6 5,000 2.0700 11/19/2019
Purchase of Class A Common Stock 20,000 19.2312 11/20/2019
Purchase of Class A Common Stock 10,000 19.1578 11/20/2019
Purchase of Class A Common Stock 10,000 18.7846 11/20/2019
Purchase of January 2020 Call Option ($22 Strike Price)2 5,000 1.5000 11/20/2019
Purchase of December 2019 Call Option ($17 Strike Price)6 10,000 2.7500 11/20/2019
Sale of January 2021 Call Option ($20 Strike Price)10 (10,000) 5.0000 11/20/2019
Sale of February 2020 Call Option ($19 Strike Price)1 (10,000) 2.9000 11/20/2019
Sale of May 2020 Call Option ($19 Strike Price)11 (10,000) 3.9000 11/20/2019
Purchase of Class A Common Stock 10,000 17.6407 11/21/2019
Purchase of February 2020 Call Option ($20 Strike Price)1 5,000 2.0552 11/21/2019

 

 

CUSIP No. 42225K106

 

Purchase of February 2020 Call Option ($24 Strike Price)1 2,500 1.1300 11/21/2019
Purchase of May 2020 Call Option ($19 Strike Price)11 10,000 3.2000 11/21/2019
Purchase of May 2020 Call Option ($25 Strike Price)11 10,000 1.7500 11/21/2019
Purchase of December 2019 Call Option ($15 Strike Price)6 3,100 3.1700 11/21/2019
Purchase of December 2019 Call Option ($16 Strike Price)6 7,500 2.5500 11/21/2019
Purchase of December 2019 Call Option ($17 Strike Price)6 5,000 2.3500 11/21/2019
Purchase of December 2019 Call Option ($18 Strike Price)6 5,000 1.5500 11/21/2019
Purchase of January 2020 Call Option ($10 Strike Price)2 10,000 7.0000 11/22/2019
Purchase of January 2020 Call Option ($25 Strike Price)2 10,000 0.6500 11/22/2019
Purchase of January 2022 Call Option ($10 Strike Price)12 5,000 9.5000 11/22/2019
Purchase of February 2020 Call Option ($30 Strike Price)1 7,500 0.4500 11/22/2019
Purchase of May 2020 Call Option ($10 Strike Price)11 10,000 7.4000 11/22/2019
Purchase of Class A Common Stock 17,780 16.0581 11/22/2019
Purchase of Class A Common Stock 35,000 17.0922 11/22/2019
Purchase of February 2020 Put Option ($13 Strike Price)8 7,600 1.3500 11/25/2019
Purchase of May 2020 Call Option ($24 Strike Price)11 10,000 2.4000 11/25/2019
Purchase of December 2019 Put Option ($14 Strike Price)3 10,000 0.3500 11/25/2019
Purchase of December 2019 Put Option ($16 Strike Price)3 10,000 0.9000 11/25/2019
Purchase of December 2019 Put Option ($17 Strike Price)3 2,700 1.2000 11/25/2019
Sale of January 2021 Call Option ($18 Strike Price)10 (10,000) 5.0000 11/25/2019
Sale of December 2019 Call Option ($16 Strike Price)6 (10,000) 2.0500 11/25/2019
Purchase of Class A Common Stock 10,000 18.7057 11/26/2019
Purchase of Class A Common Stock 5,000 18.9874 11/26/2019
Sale of January 2021 Call Option ($20 Strike Price)10 (10,000) 5.0000 11/26/2019
Sale of February 2020 Call Option ($19 Strike Price)1 (10,000) 3.0000 11/26/2019

 

 

CUSIP No. 42225K106

 

Sale of May 2020 Call Option ($18 Strike Price)11 (10,000) 4.5000 11/26/2019
Purchase of Class A Common Stock 5,000 19.4237 11/27/2019
Sale of February 2020 Call Option ($19 Strike Price)1 (10,000) 3.2000 11/27/2019
Sale of May 2020 Call Option ($19 Strike Price)11 (10,000) 4.5000 11/27/2019
Sale of May 2020 Call Option ($20 Strike Price)11 (10,000) 4.3000 11/27/2019
Purchase of Class A Common Stock 24,444 18.3267 11/29/2019
Sale of January 2021 Call Option ($15 Strike Price)10 (10,000) 6.7000 11/29/2019
Sale of January 2021 Call Option ($18 Strike Price)10 (10,000) 5.5000 11/29/2019
Sale of January 2020 Call Option ($19 Strike Price)2 (10,000) 2.0000 11/29/2019
Sale of January 2020 Call Option ($20 Strike Price)2 (10,000) 1.7500 11/29/2019
Sale of February 2020 Call Option ($18 Strike Price)1 (10,000) 3.1000 11/29/2019
Sale of May 2020 Call Option ($18 Strike Price)11 (20,000) 4.3000 11/29/2019
Sale of May 2020 Call Option ($19 Strike Price)11 (10,000) 4.1000 11/29/2019
Purchase of Class A Common Stock 10,000 18.4421 12/02/2019
Purchase of December 2019 Put Option ($15 Strike Price)3 10,000 0.4000 12/02/2019
Purchase of December 2019 Put Option ($16 Strike Price)3 1,000 0.6000 12/02/2019
Purchase of December 2019 Put Option ($17 Strike Price)3 7,300 1.0000 12/02/2019
Sale of January 2021 Call Option ($20 Strike Price)10 (10,000) 4.6000 12/02/2019
Sale of January 2020 Call Option ($17.50 Strike Price)2 (10,000) 2.5000 12/02/2019
Sale of January 2022 Call Option ($25 Strike Price)12 (10,000) 5.0000 12/02/2019
Sale of February 2020 Call Option ($17 Strike Price)1 (10,000) 3.2000 12/02/2019
Sale of May 2020 Call Option ($15 Strike Price)11 (10,000) 5.0000 12/02/2019
Sale of May 2020 Call Option ($17 Strike Price)11 (10,000) 4.1000 12/02/2019
Sale of May 2020 Call Option ($18 Strike Price)11 (10,000) 4.0000 12/02/2019
Purchase of Class A Common Stock 5,704 19.5316 12/03/2019

 

 

CUSIP No. 42225K106

 

Purchase of February 2020 Put Option ($15 Strike Price)8 5,000 1.8500 12/03/2019
Purchase of February 2020 Put Option ($18 Strike Price)8 1,000 3.5000 12/03/2019
Purchase of December 2019 Put Option ($14 Strike Price)3 5,000 0.2000 12/03/2019
Purchase of December 2019 Put Option ($15 Strike Price)3 3,000 0.3000 12/03/2019
Purchase of December 2019 Put Option ($22 Strike Price)3 10,000 3.8000 12/03/2019
Purchase of Class A Common Stock 4,503 18.8114 12/04/2019
Sale of January 2020 Call Option ($19 Strike Price)2 (14,800) 2.5000 12/04/2019
Sale of January 2020 Call Option ($20 Strike Price)2 (10,000) 2.0000 12/04/2019
Sale of February 2020 Call Option ($18 Strike Price)1 (1,700) 3.6000 12/04/2019
Sale of February 2020 Call Option ($19 Strike Price)1 (10,000) 3.1000 12/04/2019
Purchase of Class A Common Stock 2,702 19.1420 12/05/2019
Purchase of February 2020 Put Option ($16 Strike Price)8 5,000 2.2500 12/05/2019
Purchase of Class A Common Stock 8,870 19.2420 12/06/2019
Sale of February 2020 Call Option ($21 Strike Price)1 (5,000) 2.5500 12/06/2019
Purchase of Class A Common Stock 1,529 18.8768 12/09/2019
Purchase of January 2020 Put Option ($20 Strike Price)7 5,000 3.5000 12/09/2019
Sale of February 2020 Call Option ($16 Strike Price)1 (10,000) 4.5000 12/09/2019
Sale of February 2020 Call Option ($17 Strike Price)1 (10,000) 3.9000 12/09/2019
Sale of February 2020 Call Option ($18 Strike Price)1 (10,000) 3.4000 12/09/2019
Purchase of Class A Common Stock 2,753 18.2564 12/10/2019
Purchase of Class A Common Stock 3,181 18.3970 12/11/2019
Purchase of Class A Common Stock 2,457 19.1147 12/12/2019
Purchase of January 2020 Call Option ($25 Strike Price)2 25,000 0.8500 12/13/2019
Purchase of Class A Common Stock 12,500 19.2914 12/13/2019
Sale of January 2021 Call Option ($35 Strike Price)10 (10,000) 2.5000 12/13/2019

 

 

CUSIP No. 42225K106

 

Sale of May 2020 Call Option ($21 Strike Price)11 (10,000) 3.6000 12/13/2019
Sale of May 2020 Call Option ($22 Strike Price)11 (5,000) 3.2000 12/13/2019
Purchase of Class A Common Stock 3,059 20.1689 12/16/2019
Purchase of May 2020 Call Option ($22 Strike Price)11 2,200 5.2000 12/16/2019
Sale of Class A Common Stock Upon Assignment of December 2019 Call Options ($16 Strike Price) (300) 16.0000 12/17/2019
Purchase of Class A Common Stock 4,282 21.7189 12/17/2019
Purchase of January 2020 Call Option ($19 Strike Price)2 10,000 3.9000 12/17/2019
Purchase of February 2020 Call Option ($17 Strike Price)1 10,000 5.7000 12/17/2019
Purchase of February 2020 Call Option ($19 Strike Price)1 10,000 4.6000 12/17/2019
Purchase of December 2019 Put Option ($23 Strike Price)3 10,000 1.3500 12/17/2019
Sale of Class A Common Stock Upon Assignment of December 2019 Call Options ($16 Strike Price) (700) 16.0000 12/18/2019
Purchase of December 2019 Call Option ($16 Strike Price)6 700 7.0000 12/18/2019
Purchase of Class A Common Stock 11,000 23.1513 12/18/2019
Purchase of January 2020 Call Option ($19 Strike Price)2 10,000 4.9000 12/18/2019
Purchase of January 2020 Call Option ($20 Strike Price)2 10,000 4.5000 12/18/2019
Purchase of December 2019 Call Option ($25 Strike Price)6 9,000 7.0000 12/18/2019
Sale of January 2021 Call Option ($20 Strike Price)10 (15,000) 7.6000 12/18/2019
Sale of January 2021 Call Option ($22 Strike Price)10 (15,000) 6.7333 12/18/2019
Sale of May 2020 Call Option ($22 Strike Price)11 (10,000) 4.9000 12/18/2019
Purchase of Class A Common Stock Upon Exercise of December 2019 Call Options ($16 Strike Price) 100 16.000 12/20/2019
Purchase of Class A Common Stock Upon Assignment of December 2019 Put Options ($25 Strike Price) 5,000 25.0000 12/20/2019
Purchase of Class A Common Stock Upon Assignment of December 2019 Put Options ($23 Strike Price) 25,000 23.0000 12/20/2019

 

CUSIP No. 42225K106

 

VOSS CAPITAL, LLC

(Through the Voss Managed Account)

 

Purchase of Class A Common Stock 5,886 27.0016 10/21/2019
Purchase of Class A Common Stock 392 27.5785 10/21/2019
Sale of January 2021 Call Option ($30 Strike Price)10 (3,900) 6.1000 10/21/2019
Sale of January 2021 Call Option ($35 Strike Price)10 (3,900) 5.0000 10/21/2019
Sale of January 2022 Put Option ($25 Strike Price)13 (3,900) 12.0000 10/21/2019
Sale of January 2021 Call Option ($25 Strike Price)10 (4,000) 6.5157 10/22/2019
Purchase of Class A Common Stock 3,924 27.0964 10/25/2019
Sale of February 2020 Call Option ($27 Strike Price)1 (2,000) 3.9000 10/25/2019
Sale of January 2020 Call Option ($26 Strike Price)2 (3,900) 3.5000 10/28/2019
Purchase of Class A Common Stock 1,000 26.4215 10/31/2019
Purchase of Class A Common Stock 392 25.3810 11/01/2019
Sale of Class A Common Stock (500) 24.5000 11/05/2019
Purchase of November 2019 Call Option ($28 Strike Price)5 3,900 0.6000 11/06/2019
Sale of Class A Common Stock (2,173) 23.9978 11/06/2019
Sale of Class A Common Stock (18,964) 24.3027 11/12/2019
Purchase of Class A Common Stock 3,995 23.5843 11/14/2019
Purchase of January 2021 Call Option ($30 Strike Price)10 2,400 4.2000 11/14/2019
Purchase of February 2020 Call Option ($27 Strike Price)1 1,200 2.0000 11/14/2019
Sale of February 2020 Put Option ($23 Strike Price)8 (4,000) 4.0000 11/14/2019
Purchase of Class A Common Stock Upon Assignment of November 2019 Put Options ($27 Strike Price) 100 27.0000 11/15/2019

 

 

CUSIP No. 42225K106

 

Purchase of Class A Common Stock Upon Assignment of November 2019 Put Options ($25 Strike Price) 2,000 25.0000 11/15/2019
Purchase of Class A Common Stock 20,000 20.7733 11/18/2019
Purchase of Class A Common Stock 15,000 19.4687 11/19/2019
Purchase of Class A Common Stock 25,000 17.1451 11/21/2019
Purchase of Class A Common Stock 15,000 17.6254 11/25/2019
Purchase of Class A Common Stock 22,500 18.6646 11/26/2019
Purchase of January 2021 Call Option ($25 Strike Price)10 4,000 4.3000 11/26/2019
Purchase of January 2021 Call Option ($30 Strike Price)10 1,500 3.3000 11/26/2019
Purchase of January 2021 Call Option ($35 Strike Price)10 3,900 2.5000 11/26/2019
Purchase of February 2020 Call Option ($27 Strike Price)1 800 1.2500 11/26/2019
Purchase of Class A Common Stock 6,800 19.4119 11/27/2019
Purchase of Class A Common Stock 30,556 18.3267 11/29/2019
Purchase of Class A Common Stock 3,796 19.5316 12/03/2019
Purchase of Class A Common Stock 2,997 18.8114 12/04/2019
Purchase of Class A Common Stock 1,798 19.1420 12/05/2019
Purchase of Class A Common Stock 5,630 19.2420 12/06/2019
Sale of February 2020 Call Option ($19Strike Price)1 (5,000) 3.3000 12/06/2019
Sale of February 2020 Call Option ($20 Strike Price)1 (5,000) 2.9000 12/06/2019
Purchase of Class A Common Stock 971 18.8768 12/9/2019
Purchase of Class A Common Stock 1,747 18.2564 12/10/2019
Purchase of Class A Common Stock 2,019 18.3970 12/11/2019
Purchase of Class A Common Stock 1,941 20.1689 12/16/2019
Purchase of January 2021 Call Option ($26 Strike Price)10 3,900 0.9300 12/16/2019
Purchase of February 2020 Call Option ($19 Strike Price)1 5,000 3.8000 12/16/2019

 

 

CUSIP No. 42225K106

 

Purchase of February 2020 Call Option ($20 Strike Price)1 5,000 3.2000 12/16/2019
Purchase of Class A Common Stock 2,718 21.7189 12/17/2019
Purchase of February 2020 Call Option ($35 Strike Price)1 3,900 0.6500 12/17/2019

 


1 Represents shares underlying exchange-listed American-style call options. These call options expire on February 21, 2020.

2 Represents shares underlying exchange-listed American-style call options. These call options expire on January 17, 2020.

3 Represents shares underlying exchange-listed American-style put options. These put options had an expiration date of December 20, 2019.

4 Represents shares underlying exchange-listed American-style put options. These put options had an expiration date of November 15, 2019.

5 Represents shares underlying exchange-listed American-style call options. These call options had an expiration date of November 15, 2019.

6 Represents shares underlying exchange-listed American-style call options. These call options had an expiration date of December 20, 2019.

7 Represents shares underlying exchange-listed American-style put options. These put options expire on January 17, 2020.

8 Represents shares underlying exchange-listed American-style put options. These put options expire on February 21, 2020.

9 Represents shares underlying exchange-listed American-style put options. These put options expire on January 15, 2021.

10 Represents shares underlying exchange-listed American-style call options. These call options expire on January 15, 2021.

11 Represents shares underlying exchange-listed American-style call options. These call options expire on May 15, 2021.

12 Represents shares underlying exchange-listed American-style call options. These call options expire on January 21, 2022.

13 Represents shares underlying exchange-listed American-style put options. These put options expire on January 21, 2022.

 

EX-99.1 2 ex991to13d10925hea_12232019.htm JOINT FILING AGREEMENT, DATED DECEMBER 23, 2019

Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Class A Common Stock, par value $0.001, of Health Insurance Innovations, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Dated: December 23, 2019 

  Voss Value Fund, L.P.
   
  By:

Voss Capital, LLC

Investment Manager

     
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

  Voss Advisors, LP  
   
  By:

Voss Advisors GP, LLC

General Partner

     
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

  Voss Advisors GP, LLC
   
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

  Voss Capital LLC
   
  By:

/s/ Travis W. Cocke

    Name: Travis W. Cocke
    Title: Managing Member

 

 

 

/s/ Travis W. Cocke

  Travis W. Cocke

 

 

GRAPHIC 3 image_001.gif GRAPHIC begin 644 image_001.gif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�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